Association between common variants in vitamin D receptor gene and susceptibility to Non-Hodgkin’s lymphoma: a case-control study

References

• Tanaka, P. Y.; Calore, E. E. P-Glycoprotein Expression in non-Hodgkin's Lymphomas of Human Immunodeficiency Virus Infected Patients. Pathol. Res. Pract 2007, 203, 1–7. DOI: 10.1016/j.prp.2006.09.004.
   PubMed Web of Science ®Google Scholar
• Bende, R. J.; van Maldegem, F.; van Noesel, C. J. Chronic Inflammatory Disease, Lymphoid Tissue Neogenesis and Extranodal Marginal Zone B-Cell Lymphomas. haematologica 2009, 94, 1109–1123. DOI: 10.3324/haematol.2009.005983.
   PubMed Web of Science ®Google Scholar
• Shen, M.; Purdue, M. P.; Kricker, A.; Lan, Q.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Chanock, S.; Rothman, N.; Armstrong, B. K. Polymorphisms in DNA Repair Genes and Risk of non-Hodgkin's lymphoma in New South Wales, Australia. haematologica 2007, 92, 1180–1185. DOI: 10.3324/haematol.11324.
   PubMed Web of Science ®Google Scholar
• Zhou, J.-Y.; He, L.-W.; Liu, J.; Yu, H.-L.; Wei, M.; Ma, W.-L.; Shi, R. Comprehensive Assessment of Associations between ercc2 lys751gln/asp312asn Polymorphisms and Risk of non- Hodgkin lymphoma. Asian Pac J Cancer Prev 2014, 15, 9347–9353. DOI: 10.7314/apjcp.2014.15.21.9347.
   PubMedGoogle Scholar
• Chen, J.; Bruce, D.; Cantorna, M. T. Vitamin D Receptor Expression Controls Proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol. 2014, 15, 6. DOI: 10.1186/1471-2172-15-6.
   PubMed Web of Science ®Google Scholar
• Sarkar, S.; Hewison, M.; Studzinski, G. P.; Li, Y. C.; Kalia, V. Role of Vitamin D in Cytotoxic T Lymphocyte Immunity to Pathogens and cancer. Crit. Rev. Clin. Lab. Sci. 2016, 53, 132–145. DOI: 10.3109/10408363.2015.1094443.
   PubMed Web of Science ®Google Scholar
• Reichrath, J.; Reichrath, S. The Relevance of the Vitamin D Endocrine System (VDES) for Tumorigenesis, Prevention, and Treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives. Dermatoendocrinol. 2013, 5, 38–50. DOI: 10.4161/derm.24156.
   PubMedGoogle Scholar
• Tang, C.; Chen, N.; Wu, M.; Yuan, H.; Du, Y. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 2009, 117, 391–399. DOI: 10.1007/s10549-008-0262-4.
   PubMed Web of Science ®Google Scholar
• Gu, H.; Wang, X.; Zheng, L.; Tang, W.; Dong, C.; Wang, L.; Shi, Y.; Shao, A.; Ding, G.; Liu, C.; et al. Vitamin D Receptor Gene Polymorphisms and Esophageal Cancer Risk in a Chinese Population: A Negative Study. Med. Oncol. 2014, 31, 827. DOI: 10.1007/s12032-013-0827-x.
   PubMed Web of Science ®Google Scholar
• Lee, Y. H.; Song, G. G. Vitamin D Receptor Gene FOKI, TaqI, BsmI, and ApaI Polymorphisms and Susceptibility to Pulmonary Tuberculosis: A meta-analysis. Genet. Mol. Res. 2015, 14, 9118–9129. DOI: 10.4238/2015.August.7.21.
   PubMed Web of Science ®Google Scholar
• Tantawy, M.; Amer, M.; Raafat, T.; Hamdy, N. Vitamin D Receptor Gene Polymorphism in Egyptian Pediatric Acute Lymphoblastic Leukemia Correlation with BMD. Meta Gene. 2016, 9, 42–46. DOI: 10.1016/j.mgene.2016.03.008.
   PubMed Web of Science ®Google Scholar
• Shaikh, F.; Baig, S.; Jamal, Q. D. Do VDR Gene Polymorphisms Contribute to Breast Cancer?. Asian Pac J Cancer Prev 2016, 17, 479–483. DOI: 10.7314/apjcp.2016.17.2.479.
   PubMedGoogle Scholar
• Mishra, D. K.; Wu, Y.; Sarkissyan, M.; Sarkissyan, S.; Chen, Z.; Shang, X.; Ong, M.; Heber, D.; Koeffler, H. P.; Vadgama, J. V. Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women. PLoS One 2013, 8, e57967. DOI: 10.1371/journal.pone.0057967.
   PubMed Web of Science ®Google Scholar
• Bogaczewicz, J.; Kaleta, B.; Sysa-Jedrzejowska, A.; Robak, E.; Lukaszkiewicz, J.; Sitkiewicz, D.; Wozniacka, A. Vitamin D Receptor Gene Polymorphism Fok I in the Polish Population Does Not Contribute to the Risk of Systemic Lupus Erythematosus. Lupus 2013, 22, 750–751. DOI: 10.1177/0961203313482743.
   PubMed Web of Science ®Google Scholar
• Tekgündüz, S. A.; Yeşil, Ş.; Ören, A. C.; Tanyildiz, H. G.; Çandir, M. O.; Bozkurt, C.; Şahin, G. Vitamin D Receptor (VDR) Polymorphisms in Pediatric Patients Presenting with Hodgkin’s Lymphoma. J. Pediatr. Hematol. Oncol 2017, 39, e59–e61.
   PubMed Web of Science ®Google Scholar
• Fang, Y.; Van Meurs, J. B.; Bergink, A. P.; Hofman, A.; Van Duijn, C. M.; Van Leeuwen, J. P.; Pols, H. A.; Uitterlinden, A. G. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res .. 2003, 18, 1632–1641. DOI: 10.1359/jbmr.2003.18.9.1632.
   PubMed Web of Science ®Google Scholar
• Iqbal, M. u N.; Khan, T. A.; Maqbool, S. A. Vitamin D Receptor Cdx-2 Polymorphism and Premenopausal Breast Cancer Risk in Southern Pakistani Patients. PLoS One. 2015, 10, e0122657 DOI: 10.1371/journal.pone.0122657.
   PubMed Web of Science ®Google Scholar
• Kelly, J. L.; Drake, M. T.; Fredericksen, Z. S.; Asmann, Y. W.; Liebow, M.; Shanafelt, T. D.; Feldman, A. L.; Ansell, S. M.; Macon, W. R.; Herr, M. M.; et al. Early Life Sun Exposure, Vitamin D-Related Gene Variants, and Risk of non-Hodgkin Lymphoma. Cancer Causes Control 2012, 23, 1017–1029. DOI: 10.1007/s10552-012-9967-0.
   PubMed Web of Science ®Google Scholar
• Yong, Y.; Lin, H. SHEsis, a Powerful Software Platform for Analyses of Linkage Disequilibrium, Haplotype Construction, and Genetic Association at Polymorphism loci. Cell Res. 2005, 15, 97–98. DOI: 10.1038/sj.cr.7290272.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Abreu, D.; Bordoni, A.; Zucca, E. Epidemiology of Hematological Malignancies. Ann.Oncol 2007, 18, i3–i8. DOI: 10.1093/annonc/mdl443.
   PubMed Web of Science ®Google Scholar
• Wróbel, T.; Mazur, G.; Dzietczenia, J.; Gębura, K.; Kuliczkowski, K.; Bogunia-Kubik, K. VEGF and bFGF Gene Polymorphisms in Patients with non-Hodgkin's Lymphoma. Biomed Res. Int. 2013, 2013, 159813. DOI: 10.1155/2013/159813.
   PubMed Web of Science ®Google Scholar
• He, J.; Liao, X.-Y.; Zhu, J.-H.; Xue, W.-Q.; Shen, G.-P.; Huang, S.-Y.; Chen, W.; Jia, W.-H. Association of MTHFR C677T and A1298C Polymorphisms with non-Hodgkin Lymphoma Susceptibility: evidence from a Meta-Analysis. Sci. Rep. 2014, 4, 6159 DOI: 10.1038/srep06159.
   PubMed Web of Science ®Google Scholar
• Qin, L.-Y.; Zhao, L.-G.; Chen, X.; Yang, Z.; Mo, W.-N. The CCND1 G870A Gene Polymorphism and Leukemia or non-Hodgkin Lymphoma Risk: A meta-analysis. Asian Pac J Cancer Prev 2014, 15, 6923–6928. DOI: 10.7314/apjcp.2014.15.16.6923.
   PubMedGoogle Scholar
• Li, G.; Li, D. Relationship between IL-10 Gene Polymorphisms and the Risk of non-Hodgkin Lymphoma: A Meta-Analysis. Hum. Immunol. 2016, 77, 418–425. DOI: 10.1016/j.humimm.2016.03.006.
   PubMed Web of Science ®Google Scholar
• Purdue, M. P.; Lan, Q.; Kricker, A.; Vajdic, C. M.; Rothman, N.; Armstrong, B. K. Vitamin D Receptor Gene Polymorphisms and Risk of non-Hodgkin's lymphoma. Haematologica 2007, 92, 1145–1146. DOI: 10.3324/haematol.11053.
   PubMed Web of Science ®Google Scholar
• Smedby, K. E.; Eloranta, S.; Duvefelt, K.; Melbye, M.; Humphreys, K.; Hjalgrim, H.; Chang, E. T. Vitamin D Receptor Genotypes, Ultraviolet Radiation Exposure, and Risk of non-Hodgkin Lymphoma. Am. J. Epidemiol. 2011, 173, 48–54. DOI: 10.1093/aje/kwq340.
   PubMed Web of Science ®Google Scholar
• Dunning, A. M.; McBride, S.; Gregory, J.; Durocher, F.; Foster, N. A.; Healey, C. S.; Smith, N.; Pharoah, P. D. P.; Luben, R. N.; Easton, D. F.; Ponder, B. A. J. No Association between Androgen or Vitamin D Receptor Gene Polymorphisms and Risk of Breast Cancer. Carcinogenesis 1999, 20, 2131–2135. DOI: 10.1093/carcin/20.11.2131.
   PubMed Web of Science ®Google Scholar
• Mittal, R. D.; Manchanda, P. K.; Bhat, S.; Bid, H. K. Association of Vitamin‐D Receptor (Fok‐I) Gene Polymorphism with Bladder Cancer in an Indian Population. BJU Int. 2007, 99, 933–937. DOI: 10.1111/j.1464-410X.2007.06657.x.
   PubMed Web of Science ®Google Scholar
• Zhou, Z.-C.; Wang, J.; Cai, Z.-H.; Zhang, Q-h.; Cai, Z.-X.; Wu, J.-H. Association between Vitamin D Receptor Gene Cdx2 Polymorphism and Breast Cancer Susceptibility. Tumour Biol. 2013, 34, 3437–3441. DOI: 10.1007/s13277-013-0919-4.
   PubMedGoogle Scholar
• Yang, C.; Jia, L.; Li, Y.; Wu, D.; Sui, C.; Jiang, Y.; Meng, F. The Vitamin D Receptor Gene ApaI Polymorphism is Associated with Increased Risk of Renal Cell Carcinoma in Chinese Population. Sci. Rep. 2016, 6, 25987 DOI: 10.1038/srep25987.
   PubMed Web of Science ®Google Scholar
• Serrano, D.; Gnagnarella, P.; Raimondi, S.; Gandini, S. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. Eur. J. Cancer Prev. 2016, 25, 85–96. DOI: 10.1097/CEJ.0000000000000132.
   PubMed Web of Science ®Google Scholar
• Alkhayal, K. A.; Awadalia, Z. H.; Vaali-Mohammed, M.-A. A.; Obeed, O. A.; Al Wesaimer, A.; Halwani, R.; Zubaidi, A. M.; Khan, Z.; Abdulla, M.-H. Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population. PloS One. 2016, 11, e0155236. DOI: 10.1371/journal.pone.0155236.
   PubMed Web of Science ®Google Scholar
• Wang, K.; Wu, G.; Li, J.; Song, W. Role of Vitamin D Receptor Gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis. BMC Cancer. 2016, 16, 674. DOI: 10.1186/s12885-016-2722-2.
   PubMed Web of Science ®Google Scholar